Results 241 to 250 of about 434,983 (266)
Some of the next articles are maybe not open access.
Study Designs for Genome‐Wide Association Studies
2008Advances in high-throughput genotyping and a flood of data on human genetic variation from the Human Genome and HapMap projects have made genome-wide association studies technically feasible. However, researchers designing such studies face a number of challenges, including how to avoid subtle systematic biases and how to achieve sufficient statistical
Peter, Kraft, David G, Cox
openaire +2 more sources
The road to genome-wide association studies
Nature Reviews Genetics, 2008The recent crop of results from genome-wide association studies might seem like a sudden development. However, this blooming follows a long germination period during which the necessary concepts, resources and techniques were developed and assembled.
openaire +2 more sources
Quality Control for Genome-Wide Association Studies
2013This chapter overviews the quality control (QC) issues for SNP-based genotyping methods used in genome-wide association studies. The main metrics for evaluating the quality of the genotypes are discussed followed by a worked out example of QC pipeline starting with raw data and finishing with a fully filtered dataset ready for downstream analysis.
Gondro, Cedric +3 more
openaire +5 more sources
Genome-wide association study for osteoarthritis
The Lancet, 2013Hao, Pang +4 more
openaire +2 more sources
[Genome-wide association studies].
Ugeskrift for laeger, 2008Within the last year, genome-wide association (GWA) studies have identified a large number of robust associations between genetic variants and common diseases. Two key premises underlie this burst of discovery. First, the HapMap project has provided a catalogue of human genetic variation.
Bjarke, Feenstra +2 more
openaire +1 more source
Advancing the use of genome-wide association studies for drug repurposing
Nature Reviews Genetics, 2021William R Reay, Murray J Cairns
exaly
Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine
Nature Reviews Drug Discovery, 2016Kathleen M Giacomini +2 more
exaly

